Pfizer falls as covid pill fails in preventive therapy trial
By The Washington Post | Published May 3, 2022
Pfizer slumped after Paxlovid, its pill for treating covid-19, failed to show benefit as a preventive therapy in a trial.
By The Washington Post | Published May 3, 2022
Pfizer slumped after Paxlovid, its pill for treating covid-19, failed to show benefit as a preventive therapy in a trial.
By The Washington Post | Published Apr 19, 2022
Treasury Secretary Janet Yellen will boycott several meetings of the powerful Group of 20 nations this week to protest Russia's invasion of Ukraine, with a conference in Washington emerging as a key test for world leaders who have condemned the war.
By The Washington Post | Published Apr 18, 2022
By The Washington Post | Published Apr 15, 2022
By The Washington Post | Published Apr 14, 2022
By The Washington Post | Published Apr 14, 2022
By The Washington Post | Published Apr 12, 2022
By Tawanda Karombo | Published Apr 6, 2022
By The Washington Post | Published Apr 5, 2022
By Reuters | Published Apr 4, 2022
By The Washington Post | Published Apr 4, 2022
By The Washington Post | Published Apr 3, 2022
By The Washington Post | Published Mar 30, 2022
By The Washington Post | Published Mar 28, 2022
By The Washington Post | Published Mar 24, 2022
By The Washington Post | Published Mar 24, 2022